Risk Alert: Before we dive into any analysis we simply note that Conatus Pharmaceuticals Inc (NASDAQ:CNAT) risk is elevated. We’ll detail it below — but that’s the lede — the option market is starting to flash those neon lights that signal “risk is rising” with an IV30 of 92.35% versus the IV30 of the S&P 500 at 8.76%. The annual high for Conatus Pharmaceuticals Inc IV30 is 146.48%.
To skip ahead of this risk alert and see if buying or selling options has been a winner in Conatus Pharmaceuticals Inc, you can go here: Getting serious about option trading.
This is a proprietary risk rating and risk alert system that looks forward for the next month — or really 30 days to be exact — and that includes weekends. The system is based on multiple interactions of data points, many of which come directly from the option market for Conatus Pharmaceuticals Inc (NASDAQ:CNAT) . The creator of this model is Capital Market Laboratories (CMLviz.com).